Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Active, not recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

July 4, 2024

Primary Completion Date

July 21, 2025

Study Completion Date

March 1, 2026

Conditions
Angina, StableCoronary Artery Disease
Interventions
OTHER

The assessment of patients with possible angina using the ORACLE pathway

"Participants will complete a digital health questionnaire, at home, that asks about their risk factors for coronary artery disease, past medical history and their symptoms.~Patients will then have a standard 12 lead ECG and perform their own personal ECG. They will then have high sensitivity cardiac troponin measured.~The results of all of the above will allow patients to be started as low, intermediate or high risk for future cardiovascular events."

Trial Locations (1)

Unknown

NHS Lothian, Edinburgh

All Listed Sponsors
lead

University of Edinburgh

OTHER

NCT06325020 - Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology | Biotech Hunter | Biotech Hunter